Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
10:31am, Thursday, 05'th Sep 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:06am, Thursday, 05'th Sep 2024
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott launches over-the-counter continuous glucose monitor in the US
09:14am, Thursday, 05'th Sep 2024
Abbott has launched its over-the-counter continuous glucose monitoring system Lingo in the United States, the company said on Thursday.
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
09:00am, Thursday, 05'th Sep 2024
Abbott Laboratories launches its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
09:00am, Thursday, 05'th Sep 2024
Abbott Laboratories on Thursday announced its over-the-counter continuous glucose monitor Lingo is available in the U.S. Lingo can be purchased without a prescription, and it's intended for adults who
Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
09:00am, Thursday, 05'th Sep 2024
Designed for people interested in improving their overall health and wellness Provides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and lif
Should You Continue to Retain ABT Stock in Your Portfolio Now?
07:16am, Thursday, 05'th Sep 2024
Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.
Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression
09:00am, Wednesday, 04'th Sep 2024
The U.S. FDA granted Abbott Breakthrough Device designation to explore deep brain stimulation (DBS) for treatment-resistant depression (TRD) as an option to improve the lives of people with this debil
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
06:50pm, Tuesday, 03'rd Sep 2024
In the latest trading session, Abbott (ABT) closed at $114.66, marking a +1.23% move from the previous day.
Why Abbott Stock Looks More Attractive Than Its Medical Devices Peer
05:00am, Tuesday, 03'rd Sep 2024
Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT.
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?
12:47pm, Monday, 02'nd Sep 2024
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their bu
10 Dividend Aristocrat Bargains Too Good To Miss
07:00am, Saturday, 31'st Aug 2024
Peter Lynch achieved 29% annual returns for 13 years, focusing on safety, quality, and growth at a reasonable price, or GARP. Lynch popularized the PEG (price/earnings/growth) ratio. During the last 3
3 Fortune 500 Industry Leaders Boast Ideal August Dividends
05:17am, Saturday, 31'st Aug 2024
The June/July 2024 edition of Fortune revealed the 500 biggest U.S. companies by revenue and profits. Dogcatcher's quest to sniff-out the best dividend-buys focused on 66 industry-leaders (IL) using Y
10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead
07:00am, Friday, 30'th Aug 2024
The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
06:45am, Friday, 30'th Aug 2024
Abbott Labs produces medications as just one of its revenue sources. AbbVie has shown a knack for expanding the markets of its drugs.
